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ARF (p19 ARF in the mouse) plays a central role in the regulation of cellular proliferation. Although the capacity of p14
ARF to induce a cell cycle arrest in G1 phase depends on a functional p53/p21-signaling axis, the G2 arrest triggered by p14
ARF is p53/p21-independent. Using isogeneic HCT116 cells either wild-type or homozygously deleted for p21, 14-3-3r or both, we further investigated the cooperative effect of p21 and 14-3-3r on cell cycle regulation and apoptosis induction by p14 ARF . In contrast to DNA damage, which induces mitotic catastrophe in 14-3-3r-deficient cells, we show here that the expression of p14 ARF triggers apoptotic cell death, as evidenced by nuclear DNA fragmentation and induction of pan-caspase activities, irrespective of the presence or absence of 14-3-3r. The activation of the intrinsic mitochondrial apoptosis pathway by p14 ARF was confirmed by cytochrome c release from mitochondria and induction of caspase-9-(LEHDase) and caspase-3/7-like (DEVDase) activities. Moreover, 14-3-3r/p21 double-deficient cells were exceedingly sensitive to apoptosis induction by p14
ARF as compared to wild-type cells or cells lacking either gene alone. Notably, p14 ARF -induced apoptosis was preceded by an arrest in the G2 phase of cell cycle, which coincided with downregulation of cdc2 (cdk1) protein expression and lack of its nuclear localization. This indicates that p14 ARF impairs mitotic entry by targeting the distal DNA damage-signaling pathway and induces apoptotic cell death, rather than mitotic catastrophe, out of a transient G2 arrest. Furthermore, our data delineate that the disruption of G2/M cell cycle checkpoint control critically determines the sensitivity of the cell toward p14
Introduction
Genotoxic stress induced by chemodrugs or ionizing irradiation triggers an arrest in the G2 phase of the cell cycle to allow for the repair of damaged DNA. In most situations, this process depends on a functional p53/p21-signaling axis. In turn, cells deficient for p21 are hampered in their ability to arrest in the G2 phase following DNA damage and rapidly undergo mitotic catastrophe and subsequent cell death (Waldman et al., 1996; Bunz et al., 1998; Bhonde et al., 2006b) . In turn, forced expression of p21 strongly attenuates apoptosis sensitivities on DNA damage (Gorospe et al., 1996; Martinez et al., 2002; Wendt et al., 2006) . In addition to p21, 14-3-3s was shown to play a key role in regulating G2/M checkpoint function (Hermeking et al., 1997) . On transcriptional upregulation by p53, 14-3-3s impairs mitotic entry by sequestering cyclin B1/cdc2 complexes (Hermeking et al., 1997; Chan et al., 1999; Hermeking, 2003) . While the expression of 14-3-3s blocks cells in the G2 phase of the cell cycle, cells deficient for 14-3-3s are unable to maintain a stable G2 arrest, prematurely enter mitosis and die by mitotic catastrophe (Chan et al., 1999) . Notably, cells lacking both p21 and 14-3-3s are highly sensitive to DNA damage-induced cell death, indicating that p21 and 14-3-3s play complementary roles and critically determine the response of the cells to DNA damage (Chan et al., 2000; Hermeking, 2003) .
The p14 ARF tumor suppressor (p19 ARF in the mouse) is encoded at the mammalian INK4a locus (Duro et al., 1995; Mao et al., 1995; Quelle et al., 1995) . Physiologically, p14 ARF (p19 ARF ) is rapidly upregulated on oncogenic stress (de Stanchina et al., 1998; Radfar et al., 1998; Zindy et al., 1998) . By stabilizing p53 through inhibition of hdm-2 (mdm-2), p14
ARF triggers the expression of p53 target genes including p21 and bax. Ectopic expression of p19 ARF was shown to induce a p53-dependent arrest in the G1 and G2 phases of the cell cycle (Quelle et al., 1995) . Similarly, the p19 ARF -mediated induction of cycle arrest or apoptosis following oncogene expression depends on functional p53. Nonetheless, data from several in vitro models suggest that p14 ARF (p19 ARF ) regulates cell cycle arrest and apoptosis in a p53-independent manner as well (Eymin et al., 2001 (Eymin et al., , 2003 Martelli et al., 2001; Hemmati et al., 2002; Normand et al., 2005) . Furthermore, p14
ARF was shown to trigger the DNA damage-signaling pathway through ATR/Chk-1 or ATM in a p53-independent manner (Li et al., 2004; Eymin et al., 2006a, b) , indicating that p14 ARF may control cellular proliferation in a way much more complex than initially thought.
Although the G1 cell cycle arrest induced by p14 ARF depends on a functional hdm-2/p53/p21-signaling axis, expression of p14 ARF in p53-and/or p21-deficient cells triggers an arrest in the G2 phase through downregulating cdc2 (cdk1) expression and functional activity (Eymin et al., 2003 (Eymin et al., , 2006a Hemmati et al., 2005; Normand et al., 2005) . This is in line with the finding that p14 ARF triggers the DNA damage-signaling pathway in a p53/p21-independent manner (Rocha et al., 2003 Eymin et al., 2006b) . As 14-3-3s is involved in the sequestration of cyclin B1/cdc2 complexes, the loss of 14-3-3s, either alone or in combination with loss of p21, may sensitize for p14 ARF -induced cell death by deregulating G2/M checkpoint function (Hermeking et al., 1997; Graves et al., 2001; Hermeking, 2003) . We therefore investigated whether the absence of 14-3-3s, alone or in conjunction with loss of p21, alters the cell cycle behavior and apoptosis sensitivities on p14 ARF expression.
Results
Induction of G2/M arrest by p14 ARF is independent of p21 and 14-3-3s HCT116 cells, either wild-type (WT) or homozygously deleted for either 14-3-3s (14-3-3s KO), p21 (p21 KO) or both p21 and 14-3-3s (double knockout (DKO)), were infected with an adenoviral vector expressing p14 ARF (Ad-p14 ARF ) at 25 multiplicity of infection (MOI) in parallel with mock-treated (control) or control vector-infected cells (Ad-lacZ; 25 MOI) and assayed for cell cycle distribution after 48 h (Figures 1a and b) . Although WT cells arrested in the G1 phase of the cell cycle showed a corresponding decrease in the relative number of cells in the S phase, p21 KO, 14-3-3s KO or DKO cells accumulated in the G2/M phase on expression of p14 ARF . Western blot analysis revealed that p14 ARF induced both p53 and p21 protein levels in the WT cells (Figure 1c) . Notably, cells lacking functional p21, that is, p21 KO and DKO cells, readily expressed high levels of p53 protein, as reported previously (Giannakakou et al., 2001 ), which did not increase further on p14 ARF expression. Similarly, the high levels of p21 protein in the 14-3-3s KO cells were not induced further on p14 ARF expression. As expected, 14-3-3s levels were induced on infection with Ad-p14 ARF in the WT cells. In contrast, p21 KO cells exhibited high basal levels of 14-3-3s protein, which were not further inducible by p14 ARF . This constitutively high expression of 14-3-3s in the p21 KO cells may result from the increased p53, which was reported to be hyperfunctional (Blagosklonny et al., 2002) . Taken together, these results indicate that the loss of 14-3-3s does not affect the ability of p14 ARF to induce a G2/M cell cycle arrest in p53 WT cells.
As compared to WT, p21 KO or 14-3-3s KO cells, there was no decrease in the relative number of cells in the S phase of the cell cycle on expression of p14 ARF in the DKO cells (Figure 1 ). This suggests that these cells are impaired in the S phase control and still proliferate following p14 ARF expression. To confirm this hypothesis, HCT116 cells were infected with Ad-p14 ARF (25 MOI) for 48 h, pulse-labeled with 5-bromo-2-deoxyuridine (BrdU) for 30 min and analysed by flow cytometry ( Figure 2a ). As shown in Figure 2b , quantification of BrdU-positive cells as percent of cells in S phase revealed that mock-treated or control vector-infected cells deficient for either p21, 14-3-3s or both displayed an overall higher degree of BrdU incorporation as compared to the WT cells. In particular, cells lacking p21, that is p21 KO and p21/14-3-3s DKO cells, exhibited the highest rates of BrdU incorporation. Although DKO cells were impaired to undergo growth arrest on p14 ARF expression, a substantial decrease in the relative number of BrdU-positive cells was observed in the WT, p21 KO or 14-3-3s KO cells on p14 ARF expression. This suggests that the combined loss of both p21 and 14-3-3s impairs the S phase control following expression of p14 ARF .
Expression of p14
ARF induced the accumulation of cells in the G2/M phase irrespective of the presence or absence of 14-3-3s and/or p21, as evidenced by an increase in the number of cells with a 4N DNA content. To differentiate between cells arrested in the G2 phase versus M phase, we employed the bivariate analysis of DNA content and expression of mitotic protein monoclonal-2 (MPM-2) phosphoepitopes, which are selectively exposed during mitosis (Taagepera et al., 1993) . As shown in Figure 3a , infection with Ad-p14 ARF (25 MOI) failed to induce MPM-2 expression in arrested tetraploid HCT116 cells irrespective of the presence or absence of p21 and/or 14-3-3s after 48 h. However, treatment with 0.1 mg/ml nocodazole was paralleled by ARF when studied by immunofluorescence after staining with Hoechst 33258 (Figure 3c ). In contrast, a strong increase in the number of mitotic cells was observed upon treatment with 0.1 mg/ml nocodazole for 18 h. Western blot analysis revealed that p14 ARF triggered the downregulation of cdc2 protein expression in G2-arrested p21 KO, 14-3-3s 14-3-3r and p21 in p14ARF-induced cell cycle arrest and apoptosis PG Hemmati et al KO and DKO cells, whereas cdc2 protein levels remained stable in G1-arrested WT cells 48 h upon expression of p14 ARF ( Figure 3d ). Notably, expression of cyclin B1 decreased in WT, 14-3-3s KO and DKO cells, but not in p21 KO cells. In contrast, p14
ARF induced a decrease in cdc25C protein expression in all HCT116 sublines. These data indicate that p14 ARF induces an arrest in the G2 phase but not in the M phase of the cell cycle, which is independent of both p21 and 14-3-3s and dissociates from cyclin B1 and cdc25C expressions. The G2 arrest correlated, however, with the downregulation of cdc2 protein expression.
Progression from the G2 phase to mitosis depends on the timely activation of the cdc2 kinase. This involves the upregulation of cyclin B1 expression and the removal of inhibitory phosphorylation of cdc2, that is at Tyr15, prior to the nuclear translocation of cyclin B1/cdc2 complexes (Jin et al., 1996 (Jin et al., , 1998 Takizawa and Morgan, 2000) . As shown in Figure 4 14-3-3r and p21 in p14ARF-induced cell cycle arrest and apoptosis PG Hemmati et al abrogates G2/M progression by downmodulating cdc2 expression and by interfering with its nuclear localization regardless of the presence or absence of 14-3-3s or p21.
Cells void of 14-3-3s succumb to mitotic catastrophe on prolonged exposure to doxorubicin (Chan et al., 1999 (Chan et al., , 2000 . We therefore investigated whether p14 ARF induces mitotic catastrophe in cells lacking 14-3-3s, that is sKO and DKO cells, as compared to WT cells or cells solely deficient for p21. HCT116 WT, p21 KO, 14-3-3s KO and DKO cells were either infected with Ad-p14 ARF (25 MOI) or treated mock (Co: medium; lacZ: Ad-lacZ, 25 MOI) for 72 h. As a positive control, cells were exposed to epirubicin (0.1 mg/ml) for 72 h. Staining with Hoechst 33258 revealed that p14 ARF -expressing cells lacked micronucleation or enlarged nuclei indicative of mitotic catastrophe (Bhonde et al., 2006a ) ( Figure 5 ). As expected, expression of p14 ARF was paralleled by a reduction in the number of mitotic cells as compared to mock-treated or control vector-infected cells. In contrast, prolonged exposure to epirubicin resulted in a substantial increase in the number of 14-3-3s KO or DKO cells displaying micronucleation and enlarged nuclei. This was not the case in the p21 KO or the WT cells. This indicates that in contrast to treatment with the DNA-damaging agents, expression of p14 ARF does not induce mitotic catastrophe in cells void of 14-3-3s. This may be due to the downregulation of cdc2 expression and interference with mitotic entry by p14 ARF .
Prolonged expression of p14
ARF resulted in a progressive loss of viable cells. To clarify if this occurs through induction of apoptosis, HCT116 cells were infected with Ad-p14 ARF (25 MOI) and assayed for apoptotic DNA fragmentation. As shown in Figures 6a and b , infection with Ad-p14 ARF induced apoptotic DNA fragmentation after 72 h. Notably, apoptosis was substantially augmented in p21-deficient cells as compared to WT cells. Likewise, the single loss of 14-3-3s resulted in a moderate increase in cells displaying fragmented genomic DNA, whereas cells lacking both p21 and 14-3-3s were most sensitive to p14 ARF -induced apoptosis. This effect occurred in a dose-dependent manner (Figure 6c ) starting as early as 48 h after expression and further increased at 72 h ( Figure 6d) .
As compared to WT cells, loss of p21 or 14-3-3s enhanced the induction of pan-caspase activities on expression of p14 ARF , as determined by the use of a fluorescein-isothiocyanate (FITC)-labeled derivative of the pan-caspase substrate zVADfmk (Figures 7a and b) . The combined loss of both p21 and 14-3-3s markedly enhanced pan-caspase activities in a dose-dependent manner ( Figure 7c ). As shown in Figure 7d , this was preceded by the release of cytochrome c into the cytosol 48 h on expression of p14 ARF . In the same vein, p14 ARF -induced apoptosis was paralleled by the induction of caspase-9-like (LEHDase) (data not shown) and caspase-3/-7-like (DEVDase) activities (Figure 7e ). In analogy, both LEHDase and DEVDase activities were most strongly induced in cells lacking both p21 and 14-3-3s. Taken together, the combined loss of p21 and 14-3-3s substantially augments p14 ARF -induced mitochondrial apoptosis, which involves the release of cytochrome c subsequently followed by the induction of caspase-9-and caspase-3/7-like activities.
Discussion
Members of the 14-3-3 family of proteins play essential roles in the regulation of cell cycle control and apoptosis sensitivities (Hermeking, 2003) . Upon DNA damage, ataxia telangiectasia mutated (ATM) triggers the activation of the chk2 kinase, which leads to the phosphorylation of cdc25C on Ser216. This allows for the sequestration of the cdc25C phosphatase through binding to 14-3-3s. In turn, the depression of cdc25C inhibits G2/ M progression by impeding the dephosphorylation of ARF does not induce mitotic catastrophe in 14-3-3s-deficient cells. HCT116 cells were infected with the indicated adenoviral vectors (25 MOI) or treated mock (Co). As a positive control, cells were exposed to epirubicin (0.1 mg/ml). Cells displaying mitotic chromatin or micronucleation and swollen hypertrophic nuclei, the latter two indicative of mitotic catastrophe, were quantified by staining nuclei with Hoechst 33258 at 72 h after infection. Bars represent the mean ± s.d. from at least 3 Â 100 cells counted in high-power fields. MOI, multiplicity of infection.
14-3-3r and p21 in p14ARF-induced cell cycle arrest and apoptosis PG Hemmati et al cdc2 (Peng et al., 1997; Sanchez et al., 1997; Zeng and Piwnica-Worms, 1999; Graves et al., 2001) . Consequently, the loss of 14-3-3s, that is by somatic gene knockout, impairs the induction of a stable G2 cell cycle arrest on treatment with DNA-damaging agents. Instead, these cells prematurely enter mitosis and subsequently die following mitotic catastrophe (Chan et al., 1999 (Chan et al., , 2000 .
In contrast, we show here that the forced expression of p14
ARF induces the accumulation of cells in the G2 phase of the cell cycle, irrespective of the presence or absence of 14-3-3s. Notably, cells deficient for p21 or for both p21 and 14-3-3s also undergo a G2 arrest underscoring that both p53 and p21 are dispensable for executing a p14 ARF -induced G2 arrest Normand et al., 2005) . The failure of these G2-arrested cells to enter mitosis is underlined by the decreased number of cells expressing the MPM-2 phosphoepitope, that is mitotic cells displaying a 14-3-3r and p21 in p14ARF-induced cell cycle arrest and apoptosis PG Hemmati et al 14-3-3r and p21 in p14ARF-induced cell cycle arrest and apoptosis PG Hemmati et al 4N DNA content on expression of p14 ARF . This was paralleled by the absence of cells displaying mitotic figures. These findings are well in line with the observation that cdc2 is downregulated in p21 and 14-3-3s single-or double-deficient cells. Consequently, cells arrested in the G2 phase on expression of p14 ARF failed to accumulate nuclear cdc2, which in turn impairs mitotic entry. In the same vein, G2-arrested cells lack phosphohistone H3. Given that the nuclear accumulation of cyclin B1/cdc2 is a prerequisite for G2/M progression (Jin et al., 1996 (Jin et al., , 1998 Morgan et al., 1998) , this explains why p14 ARF -expressing cells arrest in G2 phase and cannot progress to mitosis.
Furthermore, this explains why 14-3-3s is dispensable for a G2 arrest in this experimental setting, as the downregulation of total cdc2 protein expression and its cytoplasmic localization are sufficient to execute a G2 arrest irrespective of the presence or absence of 14-3-3s or other upstream signaling components of the DNA damage-signaling pathway controlling the cyclin B1/ cdc2/cdc25C rheostat (Hermeking, 2003) . This further enforces the hypothesis that p14 ARF regulates G2/M progression by targeting downstream components of the DNA damage-signaling cascade, that is cdc2 (Eymin et al., 2003; Normand et al., 2005) . However, this does not exclude that p14 ARF also acts upstream of cyclin B1/ cdc2, that is by regulation of cdc25C (Eymin et al., 2006a) . Consequently, p14 ARF was shown to link oncogene-triggered signaling events to the DNAdamage pathway by inducing ATR/Chk1 interaction and nucleolar sequestration of ATR/BRCA1 complexes . Likewise, ATM may contribute to the antiproliferative effects of p14 ARF (Li et al., 2004) , suggesting that, based on their functional redundancy, both ATM/chk2 and ATR/chk1 may be involved in the p53-independent DNA-damage response triggered by p14 ARF (Eymin et al., 2006b) . Notably, we observed the p21/14-3-3s-independent downregulation of cdc25C following p14 ARF expression. Previous data establish that p14 ARF -induced apoptosis is independent of p53 (Hemmati et al., 2002) . Instead, loss of functional p21 strongly sensitized for p14 ARFinduced cell death indicating that intact restriction point control at the G1/S and G2/M boundaries is critical . Therefore, we investigated whether the loss of 14-3-3s, an important regulator at the G2/M restriction point, influences p14 ARF -induced cell death. Indeed, loss of 14-3-3s substantially enhanced sensitivity toward p14 ARF -induced apoptosis, which was further augmented by the additional loss of p21. This is in line with a study investigating the apoptosis sensitivity of cells deficient for p21 and/ or 14-3-3s as compared to WT cells (Chan et al., 2000) . There, p21/14-3-3s double-deficient cells were most sensitive toward apoptosis induction by exogenous p53 or 5-FU as compared to cells lacking either gene alone. The same group showed that 14-3-3s-deficient cells succumb to mitotic catastrophe on exposure to DNAdamaging agents (Chan et al., 1999 (Chan et al., , 2000 . Here, expression of p14 ARF failed to induce morphological features of mitotic catastrophe (Bhonde et al., 2006a) . Instead, these cells showed condensed nuclei typical for apoptotic cell death. In contrast, loss of 14-3-3s allowed for the induction of cell death by mitotic catastrophe following exposure to doxorubicin. This is remarkable considering that both anticancer drugs and p14 ARF were shown to trigger a DNA-damage response by activation of checkpoint kinases . Moreover, p14 ARF -induced cell death is subject to inhibition by Bcl-x L (Hemmati et al., 2002) and relies largely on Bax and/or Bak . This, together with the massive induction of caspase activities, indicates that p14 ARF induces apoptotic cell death and not mitotic catastrophe. This and the decrease of cells entering mitosis delineate that apoptosis occurs out of G2 phase of the cell cycle without prior mitotic entry.
Nonetheless, the question arises how the loss of 14-3-3s sensitizes for apoptosis induction following ARF primarily depends on p53 and p21 . In contrast, the induction of a G2 cell cycle arrest is mediated by the functional inactivation of cdc2 (cdk-1) by p14 ARF , particularly in cells lacking functional p53 and/or p21. This p14 ARF -induced G2 arrest is followed by apoptotic cell death (a). Inactivation of cdc2 impairs mitotic entry. Therefore, and in contrast to DNA damage (b), 14-3-3s is dispensable for blocking mitotic catastrophe during p14 ARF -induced cell death. Nevertheless, cells lacking p21 and/or 14-3-3s are more sensitive toward p14 ARF -induced apoptosis due to the lack of a stable G1 arrest on forced expression of p14 ARF .
14-3-3r and p21 in p14ARF-induced cell cycle arrest and apoptosis PG Hemmati et al expression of p14 ARF . Loss of 14-3-3s allows for an untimed exit from the G2 phase following DNA damage. This results in massive cell death by mitotic catastrophe (Chan et al., 1999 (Chan et al., , 2000 . In contrast, the expression of p14 ARF triggers the downregulation of cdc2, which primarily arrests cells in the G2 phase. In the 14-3-3s-deficient cells, this is paralleled by a decrease in cyclin B1 expression. However, cells do not progress into the M phase, but die. This suggests that p14 ARF generates conflicting G2/M checkpoint signals, which then trigger the mitochondrial apoptosis pathway out of the G2 phase. Furthermore, 14-3-3s was shown to sequester the pro-apoptotic BH3-only protein Bad, which may attenuate apoptosis sensitivities through a relative increase of anti-apoptotic Bcl-2 or Bcl-x L (Zha et al., 1996; Datta et al., 2000) . In the same vein, 14-3-3s was proposed to negatively regulate the functional activity of Bax (Samuel et al., 2001; Nomura et al., 2003) .
As reported previously, HCT116 cells lacking p21 express high levels of p53 ( Figure 1c ) (Giannakakou et al., 2001 ). Furthermore, p53 was shown to be hyperfunctional in these cells (Blagosklonny et al., 2002) . Consequently, loss of p21 may sensitize for p14 ARF -induced apoptosis through activation of a p53-triggered mitochondrial death pathway . This would explain the increased sensitivities of the DKO cells toward p14 ARF -induced apoptosis as compared to the 14-3-3s KO cells. In the same vein, loss of p21 disables the induction of a p53-mediated cell cycle arrest. This, in turn, was shown to sensitize for apoptosis induction following diverse pro-apoptotic stimuli Sohn et al., 2006; Wendt et al., 2006; Ja¨nicke et al., 2007) . Recently, p21 was reported to block apoptosis downstream of mitochondria by inhibiting caspase-9 activation (Sohn et al., 2006) . This would explain why there is no major difference in the degree of cytochrome c release, although caspase-9-and caspase-3/-7-like activities as well as apoptosis sensitivities markedly differ between the HCT116 sublines on expression of p14 ARF . In p53-deficient cells, p14 ARF -induced apoptosis is fully independent of p53 and Bax, but depends on Bak. In contrast, p14 ARF -induced apoptosis is mediated by a Bax/Bak-dependent signaling cascade in p53-proficient cells. This differential requirement for the activation of Bax and/or Bak suggests that the regulation and activation of BH3-only proteins, the main activators of Bax and Bak, may play a central role in p14 ARF -induced apoptosis. Consequently, expression of p14 ARF may regulate the expression and functional activity of BH3-only proteins other than Bad to sensitize for mitochondrial apoptosis.
Caspase activation is functionally relevant in p14 ARF -induced cell death, and apoptosis can be inhibited in the presence of broad spectrum or DEVDfmk peptide inhibitors (Hemmati et al., 2002 . Our data on mitotic arrest and mitotic catastrophe indicate that p14 ARF utilizes a signaling pathway that is, at least in part, distinct from that triggered by DNA-damaging agents. In line with this, we show that expression of p14 ARF induces a G2 arrest by downregulating cdc2 expression, which may explain why mitotic entry is impaired. This downregulation of cdc2 expression by p14 ARF occurs on the post-translational level by destabilizing the cdc2 protein (Eymin et al., 2003; Normand et al., 2005) . In turn, downregulation of cdc2 expression by p14 ARF may abrogate the untimed entry of cdc2 into the nucleus even in checkpoint-deficient cells that lack p21 and/or 14-3-3s. Cdc2-mediated mitotic entry has been proposed to play a central role in mitotic catastrophe (Chan et al., 1999 (Chan et al., , 2000 . Therefore, our data are in agreement with the notion that 14-3-3s is required to prevent mitotic catastrophe following DNA damage. However, the p14 ARF -induced G2 arrest is independent of 14-3-3s (and p21). Instead of promoting mitotic catastrophe, loss of 14-3-3s and/or p21 facilitated a G2 arrest followed by apoptotic cell death out of the G2 phase but not out of the M phase of the cell cycle (Figure 8 ). This appears to be related with the sequestration of cdc2 by p14 ARF in checkpoint-deficient cells.
Materials and methods
Cell culture HCT116 WT cells and their isogeneic sublines, HCT116 p21-/-(p21 KO) (Waldman et al., 1995) , HCT116 14-3-3s-/-(14-3-3s KO) (Chan et al., 1999) and HCT116 14-3-3s-/-/p21-/-(DKO) (Chan et al., 2000) , were generously provided by Dr Bert Vogelstein, Johns Hopkins Cancer Center, Baltimore, MD, USA. Cells were cultured in McCoy's 5A medium supplemented with 10% fetal calf serum, 100 U/ml penicillin and 0.1 mg/ml streptomycin (all from Invitrogen, Karlsruhe, Germany).
Adenoviral vectors, antibodies and reagents
Ad5-CMVp14 ARF (Ad-p14 ARF ) and Ad-lacZ expressing b-galactosidase were constructed and employed as described (Hemmati et al., 2002) . Mouse monoclonal anti-p14 ARF antibody (clone 14P02) was purchased from NeoMarkers (Fremont, CA, USA). Antibodies against p21 (clone 6B6) and p53 (clone DO-1) were murine monoclonal antibodies from BD Pharmingen (Heidelberg, Germany) and were used at a dilution of 1:1000. Antibodies against 14-3-3s (Oncogene Research Products, Boston, MA, USA), Cdc25C (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and actin (SigmaAldrich, St Louis, MI, USA) were rabbit polyclonal antibodies used at dilutions of 1:200 and 1:500, respectively. Anti-p34cdc2 and anti-phospho-cdc2 (Tyr15) were both rabbit polyclonal antibodies from Cell Signaling Technologies, Beverly, MA, USA, and were used at a dilution of 1:1000. Secondary goat anti-mouse IgG and goat anti-rabbit IgG antisera coupled to horseradish peroxidase were obtained from Southern Biotechnologies (Birmingham, AL, USA) and were used at a dilution of 1:10 000.
Immunofluorescence and microscopy Cells were seeded on sterile coverslips, infected with adenoviral vectors at 25 MOI for 36 h, fixed and stained for anti-cdc2 (dilution 1:200), an anti-p14 ARF (dilution 1:200) or an antiphosphohistone H3 (Ser10) antibody (dilution 1:200) at 4 1C overnight as described . Thereafter, slides were incubated with an Alexa-fluor-488-labeled goat anti-rabbit or an Alexa-fluor-594-labeled goat anti-mouse antibody (Molecular Probes, Leiden, Netherlands) for 2 h. Slides were washed with phosphate-buffered saline containing Hoechst 33258 at 0.5 mg/ml (Sigma-Aldrich) and mounted with Mowiol solution (Merck, Bad Soden, Germany).
SDS-polyacrylamide gel electrophoresis and western blot analysis Cells were harvested, washed and lysed as described (Hemmati et al., 2002) . Samples were mixed with sample buffer (125 mM Tris/HCl, 288 mM b-mercaptoethanol, 20% glycerol, 2% SDS, 10 mg/ml bromophenol blue) and boiled for 5 min. Equal amounts of protein (20 mg per lane) were separated by SDSpolyacrylamide gel electrophoresis (SDS-PAGE). Immunoblotting and visualization of the proteins were performed using enhanced chemiluminescence (Hemmati et al., 2002) . Equal protein loading was confirmed by re-probing membranes with antibodies against actin.
Detection of cytochrome c release Cytosolic extracts were prepared as described (von Haefen et al., 2003) . Briefly, cells were harvested, washed in phosphate-buffered saline and lysed in 40 ml of hypotonic buffer (20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (pH 7.4), 10 mM KCl, 2 mM MgCl 2 , 1mM EDTA) supplemented with 1 mM phenylmethylsulfonyl fluoride and 0.75 mg/ml digitonin (both from Sigma-Aldrich). After incubation on ice for 3 min, debris was pelleted by centrifugation. Supernatants were mixed with 10 ml of 5 Â SDS-PAGE sample buffer and boiled for 5 min. Equal amounts of protein (20 mg) were separated by SDS-PAGE and subjected to western blot analysis.
Cell cycle analysis and measurement of apoptotic cell death Cells were infected with adenoviral vectors and harvested at the indicated time points. Cell cycle analysis was performed on the single-cell level by measuring the DNA content of individual cells by flow cytometry as described . Analysis was carried out with a linear amplification in the FL-2 channel of a FACScan flow cytometer (BD Pharmingen) equipped with the CellQuestPro software and quantified using ModFit. Apoptosis was determined on the single-cell level by measuring the DNA content of individual cells with a logarithmic amplification in the FL-3 channel as described (Daniel et al., 1999) . Data are given in percent of hypoploid cells, that is cells with a sub-G1 DNA content, reflecting apoptotic cells with fragmented genomic DNA.
Detection of caspase activation on the single-cell level Measurement of pan-caspase activation using an FITC-labeled conjugate of the cell permeable pan-caspase inhibitor VAD-fmk (valyl-alanyl-aspartyl-(O-methyl)-fluoro-methylketone) from Promega (Mannheim, Germany) was performed as described . Green fluorescent cells displaying activated caspases were quantified by flow cytometry.
MPM-2 labeling
Cells were infected with adenoviral vectors at 25 MOI for 48 h and stained with MPM-2 as described . Bivariate analysis of DNA content (propidium iodide) and MPM-2 antibody (FITC) was performed by flow cytometry. M-phase cells were identified as MPM-2 positive with a 4N DNA content. Incubation with 0.1 mg/ml nocodazole (SigmaAldrich) for 18 h served as a positive control for cells arrested in mitosis.
BrdU incorporation
Cells were pulse-labeled with BrdU (Sigma-Aldrich; final concentration 10 mM) 48 h after infection as described . Analysis of DNA synthesis, that is incorporation of BrdU across the cell cycle, was performed using an FITC-labeled monoclonal antibody against BrdU (BD Pharmingen). BrdU-positive cells were gated and counted as percent of cells in S phase.
